Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASYlight study of esketamine infusion for endometriosis-associated chronic pelvic pain
NL-OMON60165Phase 4Recruiting
- Sponsor
- Reinier de Graaf Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in endometriosis comparing Esketamine infusion with Placebo saline infusion (2 arms). Primary endpoint: Numeric Rating Scale score for chronic pelvic pain. Started Feb 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
endometriosis
Beyond the preview
Go deeper on NL-OMON60165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60165.